Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G FORNI

Showing results (101-110 of 326) with videos related to

Pageof 33
Sort By:
Journal of Cellular Physiology|January 14, 1999
Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukaemic cellsF Novelli, A Allione, V Wells, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytesA Allione, V Wells, G Forni, et al.
Biochimica Et Biophysica Acta|December 17, 1986
Tumour inhibition by interleukin-2 at the tumour/host interfaceG Forni, M Giovarelli, A Santoni, et al.
Research and Reports in Urology|March 13, 2024
Prognostic Biomarkers and AKI: Potential to Enhance the Identification of Post-Operative Patients at Risk of Loss of Renal FunctionRishabh Singh, James C Watchorn, Alexander Zarbock, et al.
Anaesthesia|January 12, 2023
Renal medicine in the intensive care unit: a narrative reviewN Boyer, K Horne, N M Selby, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 17, 2022
Postoperative Acute Kidney InjuryNaomi Boyer, Jack Eldridge, John R Prowle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivityG Forni, M Giovarelli, A Santoni, et al.
Shock (Augusta, Ga.)|August 14, 2018
Manipulating the Microcirculation in Sepsis - the Impact of Vasoactive Medications on Microcirculatory Blood Flow: A Systematic ReviewElizabeth K Potter, Luke Hodgson, Ben Creagh-Brown, et al.
Journal of Hypertension|December 5, 2003
Circulating sodium pump inhibitors in five volume-expanded humansWilliam McKinnon, Gwyn A Lord, Lui G Forni, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 1, 1994
[Loco-regional treatment with low and high doses of interleukin-2 of head and neck squamous cell carcinoma recurrences]G Cortesina, A De Stefani, L Majore, et al.
Pageof 33

Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
Journal of Cellular Physiology|January 14, 1999
Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukaemic cellsF Novelli, A Allione, V Wells, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytesA Allione, V Wells, G Forni, et al.
Biochimica Et Biophysica Acta|December 17, 1986
Tumour inhibition by interleukin-2 at the tumour/host interfaceG Forni, M Giovarelli, A Santoni, et al.
Research and Reports in Urology|March 13, 2024
Prognostic Biomarkers and AKI: Potential to Enhance the Identification of Post-Operative Patients at Risk of Loss of Renal FunctionRishabh Singh, James C Watchorn, Alexander Zarbock, et al.
Anaesthesia|January 12, 2023
Renal medicine in the intensive care unit: a narrative reviewN Boyer, K Horne, N M Selby, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 17, 2022
Postoperative Acute Kidney InjuryNaomi Boyer, Jack Eldridge, John R Prowle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivityG Forni, M Giovarelli, A Santoni, et al.
Shock (Augusta, Ga.)|August 14, 2018
Manipulating the Microcirculation in Sepsis - the Impact of Vasoactive Medications on Microcirculatory Blood Flow: A Systematic ReviewElizabeth K Potter, Luke Hodgson, Ben Creagh-Brown, et al.
Journal of Hypertension|December 5, 2003
Circulating sodium pump inhibitors in five volume-expanded humansWilliam McKinnon, Gwyn A Lord, Lui G Forni, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 1, 1994
[Loco-regional treatment with low and high doses of interleukin-2 of head and neck squamous cell carcinoma recurrences]G Cortesina, A De Stefani, L Majore, et al.
Pageof 33